Rovalpituzumab (Anti-DLL3)

Ask supplier a question | View on supplier's website

Rovalpituzumab (Anti-DLL3) is a humanized monoclonal antibody targeting delta-like protein 3 (DLL3). Rovalpituzumab can be used in the synthesis of antibody-drug conjugate (ADC), Rovalpituzumab Tesirine. Rovalpituzumab has activity against small cell lung cancer (SCLC). MW: 145.5 KD.

Supplier	Selleck Chemicals
Product #	A2521
Sku #	A2521-1mg*5
Pricing	1mg*5, $790.00

Feedback